Fri.Aug 12, 2022

PhRMA lies to protect pharma profits

World of DTC Marketing

PhRMA is lying to protect its profits, and the lies have reached a new height as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.

Seagen loses arbitration case to Daiichi Sankyo over cancer drug technology

Bio Pharma Dive

An arbitrator ruled against Seagen in a dispute over technology used in Enhertu and other Daiichi Sankyo drugs, stopping an attempt by Seagen to collect lucrative royalties

Drugs 207
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.

New Enhertu approval adds to growing role of well-known cancer target

Bio Pharma Dive

AstraZeneca and Daiichi Sankyo’s drug is the first medicine cleared for lung tumors with mutations to HER2, a gene known for its link to breast cancers

Gene 207

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Brexit fallout continues with batch testing concerns

Pharmaceutical Technology

More than a year and a half after the Brexit deal came into effect, the UK’s pharmaceutical industry is still trying to determine the likely impacts.

Pfizer’s new pneumococcal vaccine meets study goal in children

Bio Pharma Dive

Pfizer, which competes with Merck in this market, plans to ask the FDA for an expanded approval of its 20-valent shot later this year

More Trending

Amgen’s low tax rates draw attention of top Democratic senator

Bio Pharma Dive

Ron Wyden, D-Ore., is probing how Amgen paid an average effective tax rate of 12% over the past four years, well below the U.S. statutory rate of 21

202
202

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research.

After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide

Fierce Pharma

After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide. kdunleavy. Fri, 08/12/2022 - 09:14

Sales 114

Dismay as UK ‘drags its heels’ on AZ’s COVID antibody Evusheld

Pharma Phorum

Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has shelved plans to offer treatment with AstraZeneca’s antibody therapy Evusheld.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Two deaths after Novartis' Zolgensma put gene therapy’s liver safety in the spotlight once again

Fierce Pharma

Two deaths after Novartis' Zolgensma put gene therapy’s liver safety in the spotlight once again. Fri, 08/12/2022 - 10:54

Cumulus’ gamified dry EEG system tops lab monitoring in trial

Pharma Phorum

An at-home electroencephalogram (EEG) headset used alongside game-like cognitive tasks developed by UK company Cumulus Neuroscience has been shown to be more effective than lab-based EEG monitoring in a clinical trial.

AZ's Enhertu breaks more ground, nabbing fast FDA nod in HER2-mutant lung cancer

Fierce Pharma

AZ's Enhertu breaks more ground, nabbing fast FDA nod in HER2-mutant lung cancer. zbecker. Fri, 08/12/2022 - 10:35

83

FDA approval of Xofluza to treat influenza in children aged five years and older

The Pharma Data

Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age The FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected person.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Seagen, after $42M victory, suffers loss in ADC patent feud with Daiichi

Fierce Pharma

Seagen, after $42M victory, suffers loss in ADC patent feud with Daiichi. fkansteiner. Fri, 08/12/2022 - 15:00

83

Bayer Showcases Leadership in Breakthrough Innovations and Sustainable, Tailored Solutions to Meet Global Challenges in Agriculture

The Pharma Data

Pfizer in catch-up mode with Merck shows data that could fetch Prevnar 20 a key approval

Fierce Pharma

Pfizer in catch-up mode with Merck shows data that could fetch Prevnar 20 a key approval. kdunleavy. Fri, 08/12/2022 - 10:52

82

First HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer

The Pharma Data

Based on DESTINY-Lung02 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reported a confirmed objective response rate of 57.7% in patients with HER2-mutant disease.

Fierce Pharma Asia—Enhertu's historic nod; Hutchmed's trial wins; BeiGene, Novartis' liver cancer readout

Fierce Pharma

Fierce Pharma Asia—Enhertu's historic nod; Hutchmed's trial wins; BeiGene, Novartis' liver cancer readout. Fri, 08/12/2022 - 08:40

Monkeypox: experts give virus variants new names

The Pharma Data

A group of global experts convened by WHO has agreed on new names for monkeypox contagion variants, as part of ongoing sweats to align the names of the monkeypox complaint, contagion and variants or clades with current stylish practices. The experts agreed to name the clades using Roman numbers.

Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe

Fierce Pharma

Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe. fkansteiner. Fri, 08/12/2022 - 08:28

80

Research identifies, exploits vulnerability in certain high-risk cancers

The Pharma Data

In a study lately published in Cancer Research, a journal of the American Association for Cancer Research, a platoon of experimenters led byC. Patrick Reynolds,M.D.,Ph.D.,

DNA 52

There is a large pipeline of CAR-T cell therapies for diffuse large B-cell lymphoma

Pharmaceutical Technology

Adoptive cell therapy (ACT) is a form of cancer treatment that involves the transfer of immune cells into a patient to help fight the disease, by eliminating cancer cells. These cells can be taken originally from the patient or another individual.

New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19

The Pharma Data

A University of Minnesota adjunct professor is part of a platoon that has developed a new way to effectively deliver vaccines through mucosal apkins in the nose that could lead to better protection against pathogens like mortal immunodeficiency contagion( HIV) and SARS- CoV- 2, the contagion that causes COVID- 19.

Almac Group Reveals North American HQ Expansion Plan

Pharmaceutical Commerce

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity.

52

Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants

The Pharma Data

Azenta Acquires Cold Chain Manufacturer

Pharmaceutical Commerce

In deal to be finalized by October, purchases B Medical Systems for $423 million.

Ceapro and McMaster extend partnership to develop Covid-19 therapy

Pharmaceutical Technology

Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis.

Improving Out-of-Pocket Cost Transparency For Physicians

Drug Channels

Today’s guest post comes from Divya Iyer, VP, Strategy and Business Development, Pharma Manufacturer Solutions at GoodRx. Divya highlights new GoodRx research on the out-of-pocket cost gap between brand-name and generic prescriptions.

Drugs 61

Why reshoring drug production means embracing continuous manufacturing

Pharma Phorum

Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions. The COVID-19 pandemic led to skyrocketing demand for some products while simultaneously constraining supplies due to logistical breakdowns and protectionist practices.

Chatting with “Boomerang” Steve Morrissey

Intouch Solutions

“Boomerangs” are employees who leave and then return… and we’re known for the quantity, and quality, of our Boomerangs! Here, we catch up with Steve Morrissey, Director, Digital Production, EVERSANA ENGAGE, about his experience.

J&J says it will stop selling all talc products next year

Pharma Phorum

Johnson & Johnson has said it will stop selling talc-based baby powder products globally next year, two years after halting sales in the US and Canada.

Which pharmaceutical companies have the most drug patents in Morocco?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Morocco. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Morocco?

Drugs 52

Clariness, DailyBreath partner to drive recruitment in asthma trials

Pharma Phorum

Patient recruitment specialist Clariness will deploy an app aimed at helping asthma patients monitor environment triggers and report symptoms in the clinical trials its support, thanks to a partnership with digital health firm DailyBreath.